About Genospace
Genospace is a Healthcare company based in Boston (United States) founded in 2011, and was acquired by Sarah Cannon in January 2017. Cloud-based genomic medicine software. Genospace has raised $5 million across 4 funding rounds from investors including Thomson Reuters, NIH and HHS. The company has 22 employees. Genospace offers products and services including Clinical Trial Matching, EMR-to-EDC Integration, and Study Feasibility. Its focus areas include Life Sciences, Genomics, Applied Genomics and Clinical Genomics. Its legal entity is GenoSpace LLC. Its competitors include Modernizing Medicine, Guardant Health and Natera; 3 of its 3 listed competitors have raised funding.
Company details
Genospace was founded in 2011 and is headquartered in Boston, United States. Operations focus on the genomic medicine sector, where cloud-based software is developed for precision medicine applications. Services include custom solutions for pathology laboratories, healthcare providers, research institutions, clinical development teams, and patients. Genomic data is analyzed to support therapeutic decision-making across research, lab medicine, and clinical care settings.
- Headquarters Boston, United States
- Employees 22
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Website genospace.com
- Social LinkedIn X
- Acquired by Sarah Cannon (Jan 2017)
- Legal Name Genospace Llc
- Total Equity Funding$5M (USD)
in 4 rounds
- Latest Funding Round$137K (USD), Grant
Sep 2014
- InvestorsThomson Reuters
& 3 more
- Employee Count22
- Acquired bySarah Cannon
(Jan 2017)
Products & Services of Genospace
Genospace offers a comprehensive portfolio of products and services, including Clinical Trial Matching, EMR-to-EDC Integration, and Study Feasibility.
Matches patients to oncology trials using clinical-genomic data.
Transfers EMR data to trial databases for efficient research coordination.
Assesses site enrollment potential based on historical data and metrics.
Funding Insights of Genospace
Genospace has successfully raised a total of $5M across 4 strategic funding rounds. The most recent funding activity was a Grant round of $137 thousand completed in September 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $5M
- Total Rounds 4
- Last Round Grant — $137,000
- Investors Count 3
All 4 funding rounds of Genospace with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2014 | $137,000 | Grant | – | – | |
| Sep 2014 | $136,701 | Grant | – | – | |
| Aug 2014 | $5M | Series A | – | Thomson Reuters | – |
| May 2014 | Grant | – | – | – |
4 investors in total: 4 institutional.
Investors in Genospace
Genospace has secured backing from 4 investors, including institutional investors. Prominent investors backing the company include Thomson Reuters, NIH and HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Drug discovery services are provided to the biopharma sector. | 1887 | nih.gov | United States | |
Public health and human services are overseen by HHS. | 1953 | hhs.gov | ||
Cloud-based legal management and data services are provided for businesses. | 2008 | thomsonreuters.com | Toronto, Canada | |
Oncology care, clinical trials, and patient support services in healthcare. | sarahcannon.com |
Investor details for Genospace
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Genospace
34 people are tracked at Genospace (6 in leadership, 28 in team); the tracked headcount is 22.
| Name | Role | Group |
|---|---|---|
Mick Correll | President | Leadership |
Sridhar Nuthi | CTO | Leadership |
Kathryn Hopkins-McGill | Director, Data Engineering | Leadership |
Arielle Fisher | Head Of Product | Leadership |
Dan Schlauch | Director Of Data Science | Leadership |
Andrew Mckenzie | Scientific Director | Leadership |
Huda Khadri | Data Analyst | Team |
Meredith Mattlin | Data Scientist | Team |
Teddy Kim | Data Science | Team |
Diego Crespo | Senior Scientific Data Analyst | Team |
Cooper Schumacher | Health Data Scientist | Team |
Rebecca Lachs | Scientific Data Analyst | Team |
Anup Shrestha | Manager Devops | Team |
Peyton Tiroff | Product Engineer | Team |
Stephen Weiss | Product Manager | Team |
Sunaina Santhiveeran | Product Owner II | Team |
Ching Huang | User Experience Designer | Team |
Sarah Danglo | Scientific Data Analyst II | Team |
Eric Viera | Data Science | Team |
Tarun Agrawal | Data Scientist | Team |
14 more people are available in the full profile.
Complete people profiles for Genospace
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Genospace
4 dated milestones of Genospace across 6 years, from founding to its latest funding, stage changes and deals.
- Founded Genospace is founded.
- Funding First funding round.
- Funding Latest funding round, Grant, of $137K.
- Exit Acquired by Sarah Cannon.
Competitors of Genospace
Genospace has 3 listed competitors in our database, 3 of them funded. They include Modernizing Medicine, Guardant Health and Natera.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| modmed.com | 2010 | Boca Raton, United States | $329.17M | 1,563 | AI-driven EMR and practice management software is delivered for clinics. | |
| guardanthealth.com | 2012 | Redwood, United States | $557.5M | 1,351 | Digital sequencing technology for cancer detection is developed. | |
| natera.com | 2004 | Redwood, United States | $152.1M | 3,293 | Developer of cell-free DNA testing for oncology, women’s health, and organ health |
Detailed competitors of Genospace
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as Genospace (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Genospace
Genospace was founded in 2011 and raised its 1st funding round 3 years after it was founded.
Genospace is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Genospace is a funded company, having raised a total of $5M across 4 funding rounds to date.
Genospace has 22 employees.
Genospace was founded in 2011 and is headquartered in Boston, United States. Operations focus on the genomic medicine sector, where cloud-based software is developed for precision medicine applications. Services include custom solutions for pathology laboratories, healthcare providers, research institutions, clinical development teams, and patients. Genomic data is analyzed to support therapeutic decision-making across research, lab medicine, and clinical care settings.
Genospace's top competitors include Modernizing Medicine, Guardant Health and Natera.
Genospace offers Clinical Trial Matching, EMR-to-EDC Integration, and Study Feasibility.
Genospace has 4 investors. Key investors include Thomson Reuters, NIH, HHS, and Sarah Cannon.
Genospace operates through Genospace Llc.
Yes. Genospace was acquired by Sarah Cannon in January 2017.